CAD 0.03
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | 12.71 Thousand | 1.24 Million | 34.78 Thousand |
Cost of Revenue | - | - | - | 5900.00 | 817.46 Thousand | 22.06 Thousand |
Gross Profit | - | - | - | 6816.00 | 428.7 Thousand | 12.72 Thousand |
Operating Expenses | 559.78 Thousand | 242.33 Thousand | 459.26 Thousand | 218.95 Thousand | 877.56 Thousand | 880.76 Thousand |
Selling, General and Administrative Expenses | 559.78 Thousand | 242.33 Thousand | 459.26 Thousand | 210.95 Thousand | 877.56 Thousand | 880.76 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | 8001.00 | - | - |
Cost and Expenses | 559.78 Thousand | 242.33 Thousand | 459.26 Thousand | 224.85 Thousand | 1.69 Million | 902.82 Thousand |
Operating Income | -559.78 Thousand | -242.33 Thousand | -459.26 Thousand | -212.13 Thousand | -448.85 Thousand | -868.04 Thousand |
Interest Expense | - | - | - | 174.00 | 23.19 Thousand | 5907.00 |
Income Tax Expense | - | -241.34 | -157.14 Thousand | 8.53 Million | -45.83 Thousand | 939.2 Thousand |
Earnings before Tax | -559.78 Thousand | -242.33 Thousand | -459.26 Thousand | -212.3 Thousand | -738.41 Thousand | -1.06 Million |
Net Income | -559.78 Thousand | -242.33 Thousand | -302.11 Thousand | -8.74 Million | -692.58 Thousand | -2.01 Million |
Earnings Per Share Basic | -0.03 | -0.01 | -0.02 | -0.90 | -0.07 | -0.36 |
Earnings Per Share Diluted | -0.03 | -0.01 | -0.02 | -0.90 | -0.07 | -0.36 |
Weighted Average Shares Outstanding | 17.12 Million | 16.66 Million | 12.17 Million | 9.66 Million | 9.66 Million | 5.53 Million |
Weighted Average Shares Outstanding (Diluted) | 17.12 Million | 16.66 Million | 12.17 Million | 9.66 Million | 9.66 Million | 5.53 Million |
Gross Margin | - | - | - | 0.54 | 0.34 | 0.37 |
EBIT Margin | - | - | - | 4.97 | -0.17 | -18.82 |
Profit Margin | - | - | - | -687.72 | -0.56 | -57.87 |
EBITDA | - | - | -176.31 Thousand | 63.22 Thousand | -432.89 Thousand | -783.88 Thousand |
Earnings Before Tax Margin | - | - | - | -16.68 | -0.36 | -24.95 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 23.68 Thousand | 45.92 Thousand | 26.33 Thousand | 559.78 Thousand | 198.04 Thousand | 231.75 Thousand |
Selling, General and Administrative Expenses | 23.68 Thousand | 45.92 Thousand | 26.33 Thousand | - | 198.04 Thousand | 231.75 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 23.68 Thousand | 45.92 Thousand | 26.33 Thousand | 559.78 Thousand | 198.04 Thousand | 231.75 Thousand |
Operating Income | -23.68 Thousand | -45.92 Thousand | -26.33 Thousand | -559.79 Thousand | -198.04 Thousand | -231.75 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -23.68 Thousand | -45.92 | -25.34 | -559.79 | -203.05 | -231.76 |
Earnings before Tax | -23.68 Thousand | -45.92 Thousand | -26.33 Thousand | -559.78 Thousand | -198.04 Thousand | -231.75 Thousand |
Net Income | -23.68 Thousand | -45.92 Thousand | -26.33 Thousand | -559.78 Thousand | -198.04 Thousand | -231.75 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.01 | -0.01 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 18.19 Million | 18.19 Million | 18.19 Million | 17.12 Million | 18.19 Million | 16.76 Million |
Weighted Average Shares Outstanding (Diluted) | 18.19 Million | 18.19 Million | 18.19 Million | 17.12 Million | 18.19 Million | 16.76 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -23.68 Thousand | -45.92 Thousand | -26.33 Thousand | - | -198.04 Thousand | -231.75 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
308170
CSSPF
SNEGF
BIOFILCHEM
CROISSANCE
MSIU